Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress, demonstrating that frontline maintenance therapy combining Imdelltra (tarlatamab-dlle)and Imfinzi (durvalumab) cut the risk of...
India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing...
The two-day 10th National Summit on Innovation and Inclusivity, organised under the National Health Mission (NHM), concluded with a strong emphasis on evidence-based reforms,...
Dr. Reddy’s Laboratories Ltd.a leading global pharmaceutical company, is pleased to announce it has received a Notice of Compliance (NOC) from Health Canada for...
Union Minister for Health and Family Welfare and Chemicals & Fertilizers, Shri J. P. Nadda, visited the National Institute of Pharmaceutical Education and Research...
In a significant academic reform with far-reaching implications for healthcare, pharmaceutical research, and public health innovation, the University Grants Commission (UGC) has officially introduced...
Eli Lilly has announced a major strategic move to strengthen its oncology portfolio through the acquisition of Ajax Therapeutics in a deal valued at...
In a significant boost for India’s healthcare and pharmaceutical ecosystem, the newly signed India–New Zealand Free Trade Agreement (FTA) is set to create powerful...